PE20090814A1 - Cis-imidazolinas quirales - Google Patents
Cis-imidazolinas quiralesInfo
- Publication number
- PE20090814A1 PE20090814A1 PE2008001740A PE2008001740A PE20090814A1 PE 20090814 A1 PE20090814 A1 PE 20090814A1 PE 2008001740 A PE2008001740 A PE 2008001740A PE 2008001740 A PE2008001740 A PE 2008001740A PE 20090814 A1 PE20090814 A1 PE 20090814A1
- Authority
- PE
- Peru
- Prior art keywords
- phenyl
- imidazolines
- compounds
- etoxy
- piperazin
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- GEAXLHPORCRESC-UHFFFAOYSA-N chlorocyclohexatriene Chemical class ClC1=CC=C=C[CH]1 GEAXLHPORCRESC-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- -1 CYCLOBUTYL Chemical class 0.000 abstract 1
- 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 abstract 1
- 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- XIPUIGPNIDKXJU-UHFFFAOYSA-N [CH]1CC1 Chemical class [CH]1CC1 XIPUIGPNIDKXJU-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 150000002462 imidazolines Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE IMIDAZOLINAS DE FORMULA (I) DONDE Y, X Y Z SON CADA UNO C O N; V1 Y V2 SON CADA UNO HALOGENO, CN, CF3, NITRO, ENTRE OTROS; R1 Y R2 SON CADA UNO H O CH3; R3 ES H O -C(=O)-R6, DONDE R6 ES ALQUILO INFERIOR, CICLOPROPILO, CICLOBUTILO, FENILO, ENTRE OTROS; R4 ES -OCH3, -OCH2CH3, -OCH2CH2F, ENTRE OTROS; R5 ES H, -CH3, -CF3, HALOGENO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 2-{4-[(4S,5R)-2-(2-TERT-BUTIL-4-ETOXI-PIRIMIDIN-5-IL)-4,5-BIS-(4-CLORO-FENIL)-4,5-DIMETIL-4,5-DIHIDRO-IMIDAZOL-1-CARBONIL]-PIPERAZIN-1-IL}-ACETAMIDA, [(4S,5R)-2-(2-TERT-BUTIL-4-ETOXI-PIRIMIDIN-5-IL)-4,5-BIS-(4-CLORO-FENIL)-4,5-DIMETIL-4,5-DIHIDRO-IMIDAZOL-1-IL]-[4-(1,1-DIOXO-HEXAHIDRO-TIOPIRAN-4-IL)-PIPERAZIN-1-IL]-METANONA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA INTERACCION ENTRE LA PROTEINA MDM2 Y UN PEPTIDO DE TIPO p-53 SIENDO UTILES EN EL TRATAMIENTO DE TUMORES DE MAMA, DE COLON, DE PULMON, DE PROSTATA
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97850607P | 2007-10-09 | 2007-10-09 | |
| US9275908P | 2008-08-29 | 2008-08-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20090814A1 true PE20090814A1 (es) | 2009-06-27 |
Family
ID=40149549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001740A PE20090814A1 (es) | 2007-10-09 | 2008-10-07 | Cis-imidazolinas quirales |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8513239B2 (es) |
| EP (2) | EP2325180A1 (es) |
| JP (1) | JP5324586B2 (es) |
| KR (1) | KR101203020B1 (es) |
| CN (2) | CN104710408A (es) |
| AR (1) | AR068742A1 (es) |
| AU (1) | AU2008309759A1 (es) |
| BR (1) | BRPI0817850A2 (es) |
| CA (1) | CA2701932C (es) |
| CL (1) | CL2008002982A1 (es) |
| CO (1) | CO6280486A2 (es) |
| CR (1) | CR11333A (es) |
| ES (1) | ES2395210T3 (es) |
| IL (1) | IL204653A0 (es) |
| MA (1) | MA31754B1 (es) |
| MX (1) | MX2010003868A (es) |
| PE (1) | PE20090814A1 (es) |
| RU (1) | RU2487127C2 (es) |
| TW (1) | TW200916446A (es) |
| WO (1) | WO2009047161A1 (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010080864A1 (en) * | 2009-01-12 | 2010-07-15 | Array Biopharma Inc. | Piperidine-containing compounds and use thereof |
| WO2010132873A2 (en) * | 2009-05-15 | 2010-11-18 | Northwestern University | Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase |
| US20130143905A1 (en) | 2009-12-17 | 2013-06-06 | Boehringer Ingelheim International Gmbh | Novel antagonists for ccr2 and uses thereof |
| PE20121614A1 (es) | 2009-12-17 | 2012-12-21 | Boehringer Ingelheim Int | Derivados de 6-amino,4-carbonil-pirimidina sustituida como antagonistas del receptor ccr2 |
| EP2569298B1 (en) | 2010-05-12 | 2015-11-25 | Boehringer Ingelheim International GmbH | Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| WO2011147772A1 (en) | 2010-05-25 | 2011-12-01 | Boehringer Ingelheim International Gmbh | Ccr2 receptor antagonists |
| EP2576538B1 (en) | 2010-06-01 | 2015-10-28 | Boehringer Ingelheim International GmbH | New CCR2 antagonists |
| JO2998B1 (ar) | 2010-06-04 | 2016-09-05 | Amgen Inc | مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان |
| ES2685175T3 (es) | 2010-09-30 | 2018-10-05 | St. Jude Children's Research Hospital | Imidazoles sustituidos con arilo |
| EP2651976A1 (en) * | 2010-12-16 | 2013-10-23 | Roche Glycart AG | Combination therapy of an afucosylated cd20 antibody with a mdm2 inhibitor |
| JP6093770B2 (ja) | 2011-09-27 | 2017-03-08 | アムジエン・インコーポレーテツド | 癌の治療のためのｍｄｍ２阻害剤としての複素環化合物 |
| WO2014082889A1 (en) * | 2012-11-28 | 2014-06-05 | F. Hoffmann-La Roche Ag | Novel imidazolines as dual inhibitors of mdm2 and mdmx |
| KR102196882B1 (ko) | 2012-12-20 | 2020-12-30 | 머크 샤프 앤드 돔 코포레이션 | Hdm2 억제제로서의 치환된 이미다조피리딘 |
| US11407721B2 (en) | 2013-02-19 | 2022-08-09 | Amgen Inc. | CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer |
| WO2014134201A1 (en) | 2013-02-28 | 2014-09-04 | Amgen Inc. | A benzoic acid derivative mdm2 inhibitor for the treatment of cancer |
| MX364895B (es) | 2013-03-13 | 2019-05-10 | Forma Therapeutics Inc | Nuevos compuestos y composiciones para la inhibicion de fasn. |
| MX374513B (es) | 2013-03-14 | 2025-03-06 | Amgen Inc | Compuestos de morfolinona de ácido heteroarilo como inhibidores mdm2 para el tratamiento de cáncer. |
| JOP20200296A1 (ar) | 2013-06-10 | 2017-06-16 | Amgen Inc | عمليات صنع وأشكال بلورية من mdm2 مثبط |
| US10758525B2 (en) | 2015-01-22 | 2020-09-01 | MyoKardia, Inc. | 4-methylsulfonyl-substituted piperidine urea compounds |
| ES2858151T3 (es) | 2016-05-20 | 2021-09-29 | Hoffmann La Roche | Conjugados de PROTAC-anticuerpo y procedimientos de uso |
| CN105906610B (zh) * | 2016-05-24 | 2018-10-23 | 绍兴文理学院 | 一种3-（4-苯基-1h-咪唑-5-基）-1h-吲哚衍生物及其制备方法和应用 |
| PL3415802T3 (pl) | 2017-06-14 | 2020-03-31 | Borealis Ag | Dylatacja |
| WO2019186358A1 (en) * | 2018-03-26 | 2019-10-03 | Novartis Ag | 3-hydroxy-n-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivatives |
| EP3873214A4 (en) | 2018-10-29 | 2022-07-13 | Forma Therapeutics, Inc. | Solid forms of (4-(2-fluoro-4-(1-methyl-1 h-benzo[d]imidazol-5-yl)benzoyl) piperazin-1-yl)(1-hydroxycyclopropyl)methanone |
| JP2022540678A (ja) | 2019-07-16 | 2022-09-16 | マイオカーディア，インク | （ｒ）－４－（１－（（３－（ジフルオロメチル）－１－メチル－１ｈ－ピラゾール－４－イル）スルホニル）－１－フルオロエチル）－ｎ－（イソキサゾール－３－イル）ピペリジン－１－カルボキシアミドの多形体 |
| AU2021268223B2 (en) * | 2020-05-07 | 2025-10-09 | Ono Pharmaceutical Co., Ltd. | Compound having KDM5 inhibitory activity and pharmaceutical use thereof |
| WO2023056069A1 (en) | 2021-09-30 | 2023-04-06 | Angiex, Inc. | Degrader-antibody conjugates and methods of using same |
| JP7743829B2 (ja) * | 2021-11-05 | 2025-09-25 | 小野薬品工業株式会社 | Ｋｄｍ５阻害作用を有する化合物を含有する医薬組成物 |
| WO2024240858A1 (en) | 2023-05-23 | 2024-11-28 | Valerio Therapeutics | Protac molecules directed against dna damage repair system and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02101065A (ja) | 1988-10-06 | 1990-04-12 | Tanabe Seiyaku Co Ltd | イミダゾリン誘導体及びその製法 |
| GB2351082A (en) | 1999-06-18 | 2000-12-20 | Lilly Forschung Gmbh | Synthesis of Cyclic Substituted Amidines |
| ES2301717T3 (es) | 2001-12-18 | 2008-07-01 | F. Hoffmann-La Roche Ag | Cis-2,4,5-trifenil-imidazolinas y su utilizacion para el tratamiento de tumores. |
| ES2307822T3 (es) * | 2001-12-18 | 2008-12-01 | F. Hoffmann-La Roche Ag | Cis-imidazolinas como inhibidores de mdm2. |
| DE602005011132D1 (de) | 2004-05-18 | 2009-01-02 | Hoffmann La Roche | Neuartige cis-imidazoline |
| CN101238287B (zh) | 2005-07-08 | 2011-05-11 | 维斯塔斯风力系统有限公司 | 风轮机、风轮机用的轮毂及其使用 |
| JP4870778B2 (ja) | 2005-12-01 | 2012-02-08 | エフ．ホフマン−ラ ロシュ アーゲー | 抗ガン剤として使用されるｐ５３およびｍｄｍ２タンパク質間の相互作用の阻害剤としての２，４，５−トリフェニルイミダゾリン誘導体 |
| CA2636824A1 (en) * | 2006-01-18 | 2007-07-26 | F. Hoffmann-La Roche Ag | Cis-4,5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors |
-
2008
- 2008-09-30 WO PCT/EP2008/063053 patent/WO2009047161A1/en not_active Ceased
- 2008-09-30 JP JP2010528361A patent/JP5324586B2/ja not_active Expired - Fee Related
- 2008-09-30 CA CA2701932A patent/CA2701932C/en not_active Expired - Fee Related
- 2008-09-30 CN CN201510024021.1A patent/CN104710408A/zh active Pending
- 2008-09-30 BR BRPI0817850 patent/BRPI0817850A2/pt not_active Application Discontinuation
- 2008-09-30 RU RU2010118018/04A patent/RU2487127C2/ru active
- 2008-09-30 MX MX2010003868A patent/MX2010003868A/es active IP Right Grant
- 2008-09-30 CN CN200880110704A patent/CN101821251A/zh active Pending
- 2008-09-30 EP EP10175975A patent/EP2325180A1/en not_active Withdrawn
- 2008-09-30 KR KR1020107007374A patent/KR101203020B1/ko not_active Expired - Fee Related
- 2008-09-30 ES ES08837881T patent/ES2395210T3/es active Active
- 2008-09-30 EP EP08837881A patent/EP2203437B1/en active Active
- 2008-09-30 AU AU2008309759A patent/AU2008309759A1/en not_active Abandoned
- 2008-10-07 PE PE2008001740A patent/PE20090814A1/es not_active Application Discontinuation
- 2008-10-07 CL CL2008002982A patent/CL2008002982A1/es unknown
- 2008-10-07 AR ARP080104381A patent/AR068742A1/es not_active Application Discontinuation
- 2008-10-08 TW TW097138773A patent/TW200916446A/zh unknown
- 2008-10-09 US US12/248,095 patent/US8513239B2/en not_active Expired - Fee Related
-
2010
- 2010-03-22 IL IL204653A patent/IL204653A0/en unknown
- 2010-03-24 CR CR11333A patent/CR11333A/es not_active Application Discontinuation
- 2010-03-26 CO CO10036293A patent/CO6280486A2/es not_active Application Discontinuation
- 2010-04-05 MA MA32739A patent/MA31754B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2010118018A (ru) | 2011-11-20 |
| CR11333A (es) | 2010-06-21 |
| JP5324586B2 (ja) | 2013-10-23 |
| AR068742A1 (es) | 2009-12-02 |
| EP2203437B1 (en) | 2012-11-07 |
| CA2701932A1 (en) | 2009-04-16 |
| JP2010540675A (ja) | 2010-12-24 |
| CO6280486A2 (es) | 2011-05-20 |
| MX2010003868A (es) | 2010-04-27 |
| US20090111789A1 (en) | 2009-04-30 |
| TW200916446A (en) | 2009-04-16 |
| KR101203020B1 (ko) | 2012-11-20 |
| MA31754B1 (fr) | 2010-10-01 |
| RU2487127C2 (ru) | 2013-07-10 |
| ES2395210T3 (es) | 2013-02-11 |
| EP2325180A1 (en) | 2011-05-25 |
| CN104710408A (zh) | 2015-06-17 |
| US8513239B2 (en) | 2013-08-20 |
| BRPI0817850A2 (pt) | 2015-04-07 |
| EP2203437A1 (en) | 2010-07-07 |
| WO2009047161A1 (en) | 2009-04-16 |
| CN101821251A (zh) | 2010-09-01 |
| CL2008002982A1 (es) | 2009-10-16 |
| KR20100051742A (ko) | 2010-05-17 |
| IL204653A0 (en) | 2010-11-30 |
| CA2701932C (en) | 2015-10-20 |
| AU2008309759A1 (en) | 2009-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20090814A1 (es) | Cis-imidazolinas quirales | |
| PE20080925A1 (es) | DERIVADOS DE PIRROLO[2,3-b]PIRIDINA COMO INHIBIDORES DE QUINASA, EN PARTICULAR INHIBIDORES IKK2 (O IKK BETA) | |
| PE20170186A1 (es) | Nuevos compuestos | |
| PE20110329A1 (es) | Agonistas del receptor acoplado a la proteina g piperidinilo | |
| PE20081659A1 (es) | Agonistas de gpcr | |
| PE20090592A1 (es) | Nuevos derivados de piperazina-amida | |
| PE20091656A1 (es) | Compuestos heterociclicos como inhibidores de la cinasa raf | |
| PE20142185A1 (es) | Pirrolidina-2-carboxamidas sustituidas | |
| PE20091157A1 (es) | Derivados biciclicos para usar en el tratamiento de afecciones asociadas con el receptor de androgeno - 155 | |
| PE20090775A1 (es) | Nuevos derivados de biarilo | |
| PE20121354A1 (es) | Inhibidores del virus de la hepatitis c | |
| PE20140192A1 (es) | Derivados de bencimidazol como inhibidores de cinasa pi3 | |
| PE20081783A1 (es) | Nuevas 2-aminooxazolinas como ligandos de taar1 | |
| PE20141375A1 (es) | Activadores de glucoquinasa | |
| PE20120798A1 (es) | Potentes inhibidores de molecula pequena de autofagia | |
| ATE496043T1 (de) | 3-heteroaryl (amino bzw. amido)-1- (biphenyl bzw. phenylthiazolyl) carbonylpiperdinderivate als orexinrezeptor-inhibitoren | |
| PE20081532A1 (es) | Compuestos novedosos | |
| PE20061305A1 (es) | Compuestos derivados de fenilacetamidas como inhibidores de proteincinasas | |
| PE20081884A1 (es) | Inhibidores heterociclicos de la aspartil proteasa | |
| PE20090237A1 (es) | Derivados de sulfonamidas como inhibidores de los canales de sodio | |
| PE20110298A1 (es) | Derivados de picolinamida como inhibidores de cinasa | |
| PE20120861A1 (es) | Compuestos y composiciones como inhibidores de cinasa de proteina | |
| PE20090617A1 (es) | Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa | |
| PE20140868A1 (es) | Antagonistas trpm8 y su uso en tratamientos | |
| PE20090610A1 (es) | Derivados de pirazol sustituidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |